Evidence map›Paper›PMID 26858709›Full record

ArticleFrontiers in microbiology2016

Temperature-Dependent Gentamicin Resistance of Francisella tularensis is Mediated by Uptake Modulation.

Kathleen Loughman, Jesse Hall, Samantha Knowlton, Devin Sindeldecker, Tricia Gilson, Deanna M Schmitt, James W-M Birch, Tara Gajtka, Brianna N Kobe, Aleksandr Florjanczyk and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetic Determinants of Antibiotic Resistance inFrontiers in microbiology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kathleen LoughmanDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Jesse HallDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Samantha KnowltonDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Devin SindeldeckerDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Tricia GilsonDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Deanna M SchmittDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
James W-M BirchDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Tara GajtkaDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Brianna N KobeDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Aleksandr FlorjanczykDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Jenna IngramDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
Chandra S BakshiDepartment of Microbiology and Immunology, New York Medical College Valhalla, NY, USA.
Joseph HorzempaDepartment of Natural Sciences and Mathematics, West Liberty University West Liberty, WV, USA.
West Liberty University · USNew York Medical College · US

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Stanley M. Hileman · 2012 to 2026
$61.1M
WVU &MU NEW FACULTY GRANTSP20RR016477 · NCRR · MARSHALL UNIVERSITY · PI RANKIN, GARY O · 2001 to 2011
$35.5M
Francisella tularensis invasion of human erythrocytesK22AI087703 · NIAID · WEST LIBERTY UNIVERSITY · PI HORZEMPA, JOSEPH A · 2012 to 2013
$264k
NCRR NIH HHS P20 RR016477NIAID NIH HHS K22 AI087703NIGMS NIH HHS P20 GM103434
6 · The paper itself

Abstract

Gentamicin (Gm) is an aminoglycoside commonly used to treat bacterial infections such as tularemia - the disease caused by Francisella tularensis. In addition to being pathogenic, F. tularensis is found in environmental niches such as soil where this bacterium likely encounters Gm producers (Micromonospora sp.). Here we show that F. tularensis exhibits increased resistance to Gm at ambient temperature (26°C) compared to mammalian body temperature (37°C). To evaluate whether F. tularensis was less permeable to Gm at 26°C, a fluorescent marker [Texas Red (Tr)] was conjugated with Gm, yielding Tr-Gm. Bacteria incubated at 26°C showed reduced fluorescence compared to those at 37°C when exposed to Tr-Gm suggesting that uptake of Gm was reduced at 26°C. Unconjugated Gm competitively inhibited uptake of Tr-Gm, demonstrating that this fluorescent compound was taken up similarly to unconjugated Gm. Lysates of F. tularensis bacteria incubated with Gm at 37°C inhibited the growth of Escherichia coli significantly more than lysates from bacteria incubated at 26°C, further indicating reduced uptake at this lower temperature. Other facultative pathogens (Listeria monocytogenes and Klebsiella pneumoniae) exhibited increased resistance to Gm at 26°C suggesting that the results generated using F. tularensis may be generalizable to diverse bacteria. Regulation of the uptake of antibiotics provides a mechanism by which facultative pathogens survive alongside antibiotic-producing microbes in nature.

Indexed as

antibiotic resistanceFrancisellagentamicingentamicin uptakeKlebsiellaListeria monocytogenestemperature

Identifiers

PMID26858709
PMCPMC4729955
OpenAlexW2261633013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.